《睡眠專業人士雜誌》
星期五, 七月 24, 2026
Healthcare providers are under growing pressure to improve patient access while facing staffing shortages and rising operational costs. Yet, many AI tools fail to deliver measurable financial results, leaving practices stuck in “pilot purgatory.” Patient Prism aims to solve these challenges with its AI Revenue Activation platform. The proprietary AI-driven […]
Resmed announced it has entered into a definitive agreement to sell its MatrixCare business to Frazier Healthcare Partners, a private equity firm focused exclusively on health care. This move reflects Resmed’s 2030 strategy by focusing on high-growth, scalable opportunities in sleep health, breathing health and connected home-based healthcare. The divestiture […]
Sleep medicine is at a critical point. Demand is rising, the science is expanding, and too few specialists are available to meet the need. The U.S. has just 7,500 board-certified sleep specialists to serve a population of 325 million—many of whom have sleep disorders with complex comorbidities that require ongoing, […]
Wesper announces Robert Wood Johnson University Hospital (RWJUH) Somerset has expanded monthly sleep testing capacity by 290% following the adoption of Wesper’s direct-to-patient, dropship home sleep testing model, according to a newly released whitepaper detailing the operational transformation. Prior to implementation, RWJUH Somerset faced growing demand for sleep apnea testing […]
Cardiovascular disease remains the leading cause of death worldwide, accounting for an estimated 19.8 million deaths per year.1 In the U.S. alone, it claims one life every 34 seconds.2 Despite improved opportunities for prevention, early diagnosis, and effective treatment, its prevalence continues to rise across the globe. Addressing this widespread […]
多年來，BRPT 在塑造睡眠科技領域方面發揮了關鍵作用，不僅為專業能力訂立了高標準，更確保患者能獲得優質的睡眠照護，這也彰顯了該計畫的發展歷程。BRPT 實現此目標的主要方式之一在於 […]
A significant number of people in America are walking around with undiagnosed sleep disorders. Recent studies indicate 14.5 percent of adults in the U.S. have difficulty falling asleep, and 17.8 percent had difficulty staying asleep.1 While these alarming statistics highlight the urgent need for sleep disorder testing and treatment nationwide, […]
Recent research has elevated the management of obesity in patients with sleep disorders to a prominent position in clinical practice. Obesity has been capturing attention across social media, mainstream news, and even in cultural references such as South Park specials and Jimmy Kimmel’s 2023 Oscars commentary. This heightened focus underscores […]
Apnimed, Inc., a pharmaceutical company building the industry-leading portfolio of first-in-class oral drug candidates that address the root causes of obstructive sleep apnea (OSA) and other sleep-related breathing diseases, today announced positive topline results from its pivotal Phase 3 SynAIRgy clinical trial evaluating the efficacy and safety of Apnimed’s lead […]
An American Thoracic Society-led international task force has released a guidance document to help guide clinicians on restoring elective in-person pulmonary and sleep services as COVID-19 incidence decreases in their communities. The new guidance, published online in the Annals of the American Thoracic Society, is titled “Restoring Pulmonary and Sleep Services as the […]
